1. S117 RSIV. F/HN-mediated gene therapy enables lungs to produce therapeutically relevant levels of FVIII. (12th November 2015) Authors: Pytel, KM; Paul-Smith, MC; McIntosh, J; Chan, M; Meng, C; Pringle, I; Davis, L; Inoue, M; Hasegawa, M; Hyde, SC; Gill, DR; Nathwani, AC; Alton, EWFW; Griesenbach, U Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S56 Moving lentiviral-based gene therapy into a first-in-man CF trial. (12th November 2015) Authors: Griesenbach, U; Alton, EWFW; Beekman, JM; Boyd, AC; Chan, M; Davies, JC; Davies, LA; Davidson, HE; Dekkers, JF; Gea-Sorli, S; Gill, DR; Hasegawa, M; Higgins, T; Hyndman, L; McLachlan, G; Inoue, M; Hyde, SC; Moran, C; Meng, C; Paul-Smith, MC Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗